Characterisation of Toxoplasma gondii engineered to express mouse interferon-gamma

International Journal for Parasitology

Volumn 33, Issue 13, 2003, Pages 1525-1535

  Nishikawa, Yoshifumi ^a,b   Xuenan, Xuan ^a   Makala, Levi ^a   Vielemeyer, Ole ^b   Joiner, Keith A ^b   Nagasawa, Hideyuki ^a  

^a OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Expression system; Interferon gamma; Nitric oxide; Toxoplasma gondii

Indexed keywords

ANTIBODY; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RECOMBINANT GAMMA INTERFERON;

PARASITOLOGY;

ADHERENT CELL; ANIMAL; ANIMAL CELL; ANIMAL PARASITOSIS; ARTICLE; CELL CULTURE; CELL SECRETION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EXPERIMENTAL MODEL; FEMALE; FIBROBLAST; GENE EXPRESSION; GENE EXPRESSION SYSTEM; GENE VECTOR; GENETIC ENGINEERING; GENETIC TRANSFECTION; GENETICS; HOST PARASITE INTERACTION; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; IMMUNOLOGY; MACROPHAGE; METHODOLOGY; MICROBIAL GROWTH; MOUSE; MOUSE STRAIN; NONHUMAN; PARACRINE SIGNALING; PARASITOLOGY; PARASITOSIS; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOXOPLASMA; TOXOPLASMA GONDII; TRANSGENE;

TOXOPLASMA GONDII;

EID: 0142248507     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7519(03)00204-2     Document Type: Article

References (44)

1. Adams L.B., Hibbs J.B. Jr., Taintor R.R., Krahenbuhl J.L. Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine. J. Immunol. 144:1990;2725-2729.
2. Bocci V. Roles of interferon produced in physiological conditions. Immunology. 64:1988;1-9.
3. Byrd C.M., Bolken T.C., Jones K.F., Warren T.K., Vella A.T., McDonald J., King D., Blackwood Z., Hruby D.E. Biological consequences of antigen and cytokine co-expression by recombinant Streptococcus gordonii vaccine vectors. Vaccine. 20:2002;2197-2205.
4. Charest H., Sedegah M., Yap G.S., Gazzinelli R.T., Caspar P., Hoffman S.L., Sher A. Recombinant attenuated Toxoplasma gondii expressing the Plasmodium yoelii circumsporozoite protein provides highly effective priming for CD8+ T cell-dependent protective immunity against malaria. J. Immunol. 165:2000;2084-2092.
5. Chaturvedi S., Qi H., Coleman D., Rodriguez A., Hanson P.I., Striepen B., Roos D.S., Joiner K.A. Constitutive calcium-independent release of Toxoplasma gondii dense granules occurs through the NSF/SNAP/SNARE/Rab machinery. J. Biol. Chem. 274:1999;2424-2431.
6. Coppens I., Sinai A.P., Joiner K.A. Toxoplasma gondii exploits host low-density lipoprotein receptor-mediated endocytosis for cholesterol acquisition. J. Cell Biol. 149:2000;167-180.
7. Cornetta K., Berebitsky D., Behnia M., Traycoff C., Srour E.F., Sledge G.W. A retroviral vector expressing human interferon gamma upregulates MHC antigen expression in human breast cancer and leukemia cell lines. Cancer Gene Ther. 1:1994;91-98.
8. Dai W., Pan H., Kwok O., Dubey J.P. Human indoleamine 2,3-dioxygenase inhibits Toxoplasma gondii growth in fibroblast cells. J. Interferon Res. 14:1994;313-317.
9. Daubener W., Pilz K., Seghrouchni Zennati S., Bilzer T., Fischer H.G., Hadding U. Induction of toxoplasmostasis in a human glioblastoma by interferon gamma. J. Neuroimmunol. 43:1993;31-38.
10. Denkers E.Y. T lymphocyte-dependent effector mechanisms of immunity to Toxoplasma gondii. Microbes Infect. 1:1999;699-708.
11. Di Cristina M., Ghouze F., Kocken C.H., Naitza S., Cellini P., Soldati D., Thomas A.W., Crisanti A. Transformed Toxoplasma gondii tachyzoites expressing the circumsporozoite protein of Plasmodium knowlesi elicit a specific immune response in rhesus monkeys. Infect. Immun. 67:1999;1677-1682.
12. Donald R.G., Roos D.S. Stable molecular transformation of Toxoplasma gondii: a selectable dihydrofolate reductase-thymidylate synthase marker based on drug-resistance mutations in malaria. Proc. Natl Acad. Sci. U.S.A. 90:1993;11703-11707.
13. Donald R.G., Roos D.S. Insertional mutagenesis and marker rescue in a protozoan parasite: cloning of the uracil phosphoribosyltransferase locus from Toxoplasma gondii. Proc. Natl Acad. Sci. U.S.A. 92:1995;5749-5753.
14. Fourmaux M.N., Achbarou A., Mercereau-Puijalon O., Biderre C., Briche I., Loyens A., Odberg-Ferragut C., Camus D., Dubremetz J.F. The MIC1 microneme protein of Toxoplasma gondii contains a duplicated receptor-like domain and binds to host cell surface. Mol. Biochem. Parasitol. 83:1996;201-210.
15. Garcia-Reguet N., Lebrun M., Fourmaux M.N., Mercereau-Puijalon O., Mann T., Beckers C.J., Samyn B., Van Beeumen J., Bout D., Dubremetz J.F. The microneme protein MIC3 of Toxoplasma gondii is a secretory adhesion that binds to both the surface of the host cells and the surface of the parasite. Cell. Microbiol. 2:2000;353-364.
16. Hernando R.A., Ruby J.C., Halliday G.M. Changes in epidermal Langerhans cells, gamma delta T cells and CD4 T cells after intradermal infection with recombinant vaccinia virus expressing cytokine genes. Immunol. Cell Biol. 72:1994;383-389.
17. Joiner K.A., Fuhrman S.A., Miettinen H.M., Kasper L.H., Mellman I. Toxoplasma gondii: fusion competence of parasitophorous vacuoles in Fc receptor-transfected fibroblasts. Science. 249:1990;641-646.
18. Jones T.C., Hirsch J.G. The interaction between Toxoplasma gondii and mammalian cells. II. The absence of lysosomal fusion with phagocytic vacuoles containing living parasites. J. Exp. Med. 136:1972;1173-1194.
19. Jun C.D., Kim S.H., Soh C.T., Kang S.S., Chung H.T. Nitric oxide mediates the toxoplasmastatic activity of murine microglial cells in vitro. Immunol. Invest. 22:1993;487-501.
20. Iwata A., Iwata N.M., Saito T., Hamada K., Sokawa Y., Ueda S. Cytopathic effect inhibition assay for canine interferon activity. J. Vet. Med. Sci. 58:1996;23-27.
21. Karsten V., Qi H., Beckers C.J., Reddy A., Dubremetz J.F., Webster P., Joiner K.A. The protozoan parasite Toxoplasma gondii targets proteins to dense granules and the vacuolar space using both conserved and unusual mechanisms. J. Cell Biol. 141:1998;1323-1333.
22. Kim K., Soldati D., Boothroyd J.C. Gene replacement in Toxoplasma gondii with chloramphenicol acetyltransferase as selectable marker. Science. 262:1993;911-914.
23. Kim K., Boothroyd J.C. Toxoplasma gondii: stable complementation of sag1 (p30) mutants using SAG1 transfection and fluorescence-activated cell sorting. Exp. Parasitol. 80:1995;46-53.
24. La Flamme A.C., Buckner F.S., Swindle J., Ajioka J., Van Voorhis W.C. Expression of mammalian cytokines by Trypanosoma cruzi indicates unique signal sequence requirements and processing. Mol. Biochem. Parasitol. 75:1995;25-31.
25. Langermans J.A., Van der Hulst M.E., Nibbering P.H., Hiemstra P.S., Fransen L., Van Furth R. IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha. J. Immunol. 148:1992;568-574.
26. Luft B.J., Remington J.S. AIDS commentary. Toxoplasmic encephalitis. J. Infect. Dis. 157:1988;1-6.
27. Messina M., Niesman I., Mercier C., Sibley L.D. Stable DNA transformation of Toxoplasma gondii using phleomycin selection. Gene. 165:1995;213-217.
28. Murray H.W., Szuro-Sudol A., Wellner D., Oca M.J., Granger A.M., Libby D.M., Rothermel C.D., Rubin B.Y. Role of tryptophan degradation in respiratory burst-independent antimicrobial activity of gamma interferon-stimulated human macrophages. Infect. Immun. 57:1989;845-849.
29. Nagineni C.N., Pardhasaradhi K., Martins M.C., Detrick B., Hooks J.J. Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells. Infect. Immun. 64:1996;4188-4196.
30. Neudeck A., Stachelhaus S., Nischik N., Striepen B., Reichmann G., Fischer H.G. Expression variance, biochemical and immunological properties of Toxoplasma gondii dense granule protein GRA7. Microbes Infect. 4:2002;581-590.
31. Nishikawa Y., Mishima M., Nagasawa H., Igarashi I., Fujisaki K., Otsuka H., Mikami T. Interferon-gamma-induced apoptosis in host cells infected with Neospora caninum. Parasitology. 123:2001;25-31.
32. Pfefferkorn E.R. Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc. Natl Acad. Sci. U.S.A. 81:1984;908-912.
33. Schmitz J.L., Carlin J.M., Borden E.C., Byrne G.I. Beta interferon inhibits Toxoplasma gondii growth in human monocyte-derived macrophages. Infect. Immun. 57:1989;3254-3256.
34. Schwab J.C., Beckers C.J., Joiner K.A. The parasitophorous vacuole membrane surrounding intracellular Toxoplasma gondii functions as a molecular sieve. Proc. Natl Acad. Sci. U.S.A. 91:1994;509-513.
35. Sibley L.D., Weidner E., Krahenbuhl J.L. Phagosome acidification blocked by intracellular Toxoplasma gondii. Nature. 315:1985;416-419.
36. Sibley L.D., Messina M., Niesman I.R. Stable DNA transformation in the obligate intracellular parasite Toxoplasma gondii by complementation of tryptophan auxotrophy. Proc. Natl Acad. Sci. U.S.A. 91:1994;5508-5512.
37. Simons G., Remaut E., Allet B., Devos R., Fiers W. High-level expression of human interferon gamma in Escherichia coli under control of the pL promoter of bacteriophage lambda. Gene. 28:1984;55-64.
38. Soldati D., Boothroyd J.C. Transient transfection and expression in the obligate intracellular parasite Toxoplasma gondii. Science. 260:1993;349-352.
39. Soldati D., Kim K., Kampmeier J., Dubremetz J.F., Boothroyd J.C. Complementation of a Toxoplasma gondii ROP1 knock-out mutant using phleomycin selection. Mol. Biochem. Parasitol. 74:1995;87-97.
40. Spitalny G.L., Havell E.A. Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities. J. Exp. Med. 159:1984;1560-1565.
41. Striepen B., He C.Y., Matrajt M., Soldati D., Roos D.S. Expression, selection, and organellar targeting of the green fluorescent protein in Toxoplasma gondii. Mol. Biochem. Parasitol. 92:1998;325-338.
42. Tobin J.F., Reiner S.L., Hatam F., Zheng S., Leptak C.L., Wirth D.F., Locksley R.M. Transfected Leishmania expressing biologically active IFN-gamma. J. Immunol. 150:1993;5059-5069.
43. Xu X., Dai Y., Heidenreich O., Nerenberg M.I. Adenovirus-mediated interferon-gamma transfer inhibits growth of transplanted HTLV-1 Tax tumors in mice. Hum. Gene Ther. 7:1996;471-477.
44. Yap G.S., Sher A. Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function. Immunobiology. 201:1999;240-247.